Journal
NATURE REVIEWS CLINICAL ONCOLOGY
Volume 9, Issue 4, Pages 192-194Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2012.23
Keywords
-
Categories
Ask authors/readers for more resources
In the CLASSIC study, capecitabine-oxaliplatin was an effective chemotherapy after D2 gastrectomy for stage II-IIIB gastric cancer. We compared these data with the ACTS-GC study, which was the only pivotal study proving the benefit of adjuvant chemotherapy in these patients. Long-term survival data from CLASSIC are awaited with interest.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
